Procyon Biopharma Announces Results of Their Canadian Phase II, Dose-Ranging Study For The Treatment of Hypertrophic Scarring - Fibrostat(R) multicentre study confirms safety and indicates dose for further North American clinical program (Cana

Health Concerns Blossoming for Voters (Reuters)
..."It’s bigger than Medicare alone," said John Rother, policy director of the AARP, the influential retiree lobby...

President heads back to Florida to boost brother’s re-election campaign (AP)
... fund-raising total on behalf of Republican candidates above $100 million for this year alone.......

Charity group settles charges (The Arizona Daily Star)
..."None of the money collected went to anybody in Arizona, let alone to the promised organizations," Assistant Attorney...

Roche Hepatitis Drug Pegasys Wins EU OK (Reuters)
...The approval for Pegasys covers use of the drug alone or in combination with ribavirin for adults with hepatitis C,.....

Morbidly Obese Man Living With No Power, Water (Cleveland - NewsNet5)
...Police found Jackie Roberson, 51, living alone on the third floor of a Holyoke Avenue home without electricity or wat...

Itron Issues Comments On AMR Market Growth Following Analyst’s Report (Business Wire)
... momentum continues as Itron shipped more than 850,000 modules in the first quarter of 2002 alone; -......